Mario Strazzabosco

Yale University, United States of America

Mario Strazzabosco M.D., Ph.D

Academic positions:
- Professor within the Digestive Disease Section
- Director of Transplant Hepatology
- Honorary Professor in Internal Medicine University of Navarra, Spain.
- 2000-2005 Chief Gastroenterology Section and Medical Director Liver Transplant program

All industry positions (in last five years):
None declared

Research interests:
Pathophysiology of the biliary epithelium with particular interest in Cystic fibrosis related liver diseases, Polycystic liver diseases, Alagille syndrome, biliary atresia and Caroli's disease. Hepatocarcinoma and cholangiocarcinoma. Liver transplantation; Liver Stem Cell and Liver regenerative medicine.

Any other information:
Dr Strazzabosco is Past President, Governing Board Italian Association for the Study of the Liver. He is also a grant referee for several Funding Agencies: Swiss Science Foundation, EASL, CNR, University of Padova, Paediatric Liver Foundation (UK), ZONW (The Netherlands).

He is a reviewer for: Hepatology, Gastroenterology, Journal of Hepatology, Hepatology, Digestive and Liver Diseases, J Lipid Research, Editorial Board: Journal of Hepatology. Associate Editor: Liver International (official Journal of IASL).

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Gastroenterology & Hepatology > Biliary Tract (since 01 February 2006)

Links

http://info.med.yale.edu/intmed/digdis/faculty/strazzabosco.html

All recent recommendations

• 3.2
  The hepatic stem cell niche: identification by label-retaining cell assay.
  Recommended by Rebecca Wells with Zhaodong Li, Mario Strazzabosco with Romina Fiorotto
  
• 3.0
  Identification of adult hepatic progenitor cells capable of repopulating injured rat liver.
  Recommended by Mario Strazzabosco with Romina Fiorotto
  
• 3.0
  Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
  Recommended by Mario Strazzabosco with Carlo Spirli
  
• 3.0
  Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate.
  Recommended by Mario Strazzabosco
  
• 3.0
  Development and characterization of a cholangiocyte cell line from the PCK rat, an animal model of Autosomal Recessive Polycystic Kidney Disease.
  Recommended by Mario Strazzabosco
  
• 3.0
  Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells.
  Recommended by Mario Strazzabosco
  
• 3.0
  Bicarbonate-rich choleresis induced by secretin in normal rat is taurocholate-dependent and involves AE2 anion exchanger.
  Recommended by Mario Strazzabosco
  
• 3.0
  Activation of CFTR by ASBT-mediated bile salt absorption.
  Recommended by Mario Strazzabosco